(HEN) Henkel & Co. KGaA - Ratings and Ratios
Adhesives, Sealants, Hair Care, Laundry Detergents, Household Cleaners
Description: HEN Henkel & Co. KGaA
Henkel AG & Co. KGaA is a global company operating in the adhesive technologies and consumer brands businesses, offering a diverse range of products including adhesives, sealants, and functional coatings, as well as consumer goods such as hair care, body care, laundry, and home care products. The companys product portfolio caters to various industries, including packaging, mobility, electronics, craftsmen, construction, and professional industries.
With a rich history dating back to 1876, Henkel has established itself as a leading player in its respective markets. Its consumer brands business is characterized by a strong presence in the personal care products sector, with a GICS sub-industry classification that reflects its focus on personal care products. The companys products are distributed through various channels, including brick-and-mortar stores, hair salons, and digital platforms, ensuring a wide reach and accessibility to its customers.
From a financial perspective, Henkels market capitalization stands at approximately €26.7 billion, indicating a significant market presence. The companys price-to-earnings (P/E) ratio is around 12.85, with a forward P/E of 11.44, suggesting a relatively stable valuation. Additionally, Henkels return on equity (RoE) is around 15.97%, indicating a decent return for shareholders. To further evaluate the companys performance, key performance indicators (KPIs) such as revenue growth, EBITDA margin, and dividend yield can be considered. For instance, Henkels revenue growth has been driven by its strategic focus on innovation and digitalization, while its EBITDA margin has been influenced by its efforts to optimize its supply chain and reduce costs. The companys dividend yield, which is around 2-3%, provides a relatively stable income stream for investors.
To gain a deeper understanding of Henkels financial health and operational efficiency, other KPIs such as debt-to-equity ratio, interest coverage ratio, and operating cash flow can be analyzed. For example, a debt-to-equity ratio of around 0.3-0.4 indicates a relatively conservative capital structure, while an interest coverage ratio of around 10-15 suggests a comfortable ability to service its debt. Henkels operating cash flow, which has been steadily increasing over the years, provides a solid foundation for its investment activities and dividend payments.
HEN Stock Overview
| Market Cap in USD | 33,081m |
| Sub-Industry | Personal Care Products |
| IPO / Inception |
HEN Stock Ratings
| Growth Rating | -24.6% |
| Fundamental | 83.0% |
| Dividend Rating | 34.4% |
| Return 12m vs S&P 500 | -22.2% |
| Analyst Rating | - |
HEN Dividends
| Dividend Yield 12m | 3.02% |
| Yield on Cost 5y | 3.09% |
| Annual Growth 5y | -12.94% |
| Payout Consistency | 97.1% |
| Payout Ratio | 40.6% |
HEN Growth Ratios
| Growth Correlation 3m | 64.2% |
| Growth Correlation 12m | -71.8% |
| Growth Correlation 5y | 0.3% |
| CAGR 5y | 0.08% |
| CAGR/Max DD 5y | 0.00 |
| Sharpe Ratio 12m | -0.22 |
| Alpha | -16.51 |
| Beta | 0.183 |
| Volatility | 15.61% |
| Current Volume | 85k |
| Average Volume 20d | 84.7k |
| Stop Loss | 63.6 (-3.1%) |
| Signal | -1.00 |
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income (3.33b TTM) > 0 and > 6% of Revenue (6% = 2.59b TTM) |
| FCFTA 0.15 (>2.0%) and ΔFCFTA 11.49pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 4.51% (prev 3.59%; Δ 0.92pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.18 (>3.0%) and CFO 6.38b > Net Income 3.33b (YES >=105%, WARN >=100%) |
| Net Debt (1.40b) to EBITDA (6.86b) ratio: 0.20 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.21 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (419.9m) change vs 12m ago -0.07% (target <= -2.0% for YES) |
| Gross Margin 47.94% (prev 42.76%; Δ 5.18pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 128.3% (prev 87.34%; Δ 41.00pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 16.66 (EBITDA TTM 6.86b / Interest Expense TTM 298.0m) >= 6 (WARN >= 3) |
Altman Z'' 5.23
| (A) 0.06 = (Total Current Assets 11.03b - Total Current Liabilities 9.09b) / Total Assets 35.27b |
| (B) 0.64 = Retained Earnings (Balance) 22.62b / Total Assets 35.27b |
| (C) 0.15 = EBIT TTM 4.96b / Avg Total Assets 33.58b |
| (D) 1.70 = Book Value of Equity 22.88b / Total Liabilities 13.45b |
| Total Rating: 5.23 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 82.96
| 1. Piotroski 8.0pt = 3.0 |
| 2. FCF Yield 17.60% = 5.0 |
| 3. FCF Margin 11.93% = 2.98 |
| 4. Debt/Equity 0.17 = 2.49 |
| 5. Debt/Ebitda 0.54 = 2.28 |
| 6. ROIC - WACC 9.58% = 11.98 |
| 7. RoE 15.97% = 1.33 |
| 8. Rev. Trend 3.96% = 0.20 |
| 9. Rev. CAGR 3.02% = 0.38 |
| 10. EPS Trend 32.92% = 0.82 |
| 11. EPS CAGR 26.46% = 2.50 |
What is the price of HEN shares?
Over the past week, the price has changed by -2.52%, over one month by +4.04%, over three months by +2.74% and over the past year by -8.94%.
Is Henkel & Co. KGaA a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of HEN is around 60.91 EUR . This means that HEN is currently overvalued and has a potential downside of -7.22%.
Is HEN a buy, sell or hold?
What are the forecasts/targets for the HEN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 82.5 | 25.7% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 66.6 | 1.4% |
HEN Fundamental Data Overview
Market Cap EUR = 28.40b (28.40b EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = 2.89b EUR (last quarter)
P/E Trailing = 13.11
P/E Forward = 12.3609
P/S = 1.3412
P/B = 1.3779
P/EG = 3.6347
Beta = 0.45
Revenue TTM = 43.10b EUR
EBIT TTM = 4.96b EUR
EBITDA TTM = 6.86b EUR
Long Term Debt = 2.05b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.65b EUR (from shortTermDebt, last quarter)
Debt = 3.70b EUR (Calculated: Short Term 1.65b + Long Term 2.05b)
Net Debt = 1.40b EUR (from netDebt column, last quarter)
Enterprise Value = 29.21b EUR (28.40b + Debt 3.70b - CCE 2.89b)
Interest Coverage Ratio = 16.66 (Ebit TTM 4.96b / Interest Expense TTM 298.0m)
FCF Yield = 17.60% (FCF TTM 5.14b / Enterprise Value 29.21b)
FCF Margin = 11.93% (FCF TTM 5.14b / Revenue TTM 43.10b)
Net Margin = 7.71% (Net Income TTM 3.33b / Revenue TTM 43.10b)
Gross Margin = 47.94% ((Revenue TTM 43.10b - Cost of Revenue TTM 22.44b) / Revenue TTM)
Tobins Q-Ratio = 1.28 (Enterprise Value 29.21b / Book Value Of Equity 22.88b)
Interest Expense / Debt = 4.36% (Interest Expense 161.0m / Debt 3.70b)
Taxrate = 25.38% (from yearly Income Tax Expense: 691.0m / 2.72b)
NOPAT = 3.71b (EBIT 4.96b * (1 - 25.38%))
Current Ratio = 1.21 (Total Current Assets 11.03b / Total Current Liabilities 9.09b)
Debt / Equity = 0.17 (Debt 3.70b / last Quarter total Stockholder Equity 21.73b)
Debt / EBITDA = 0.54 (Net Debt 1.40b / EBITDA 6.86b)
Debt / FCF = 0.72 (Debt 3.70b / FCF TTM 5.14b)
Total Stockholder Equity = 20.82b (last 4 quarters mean)
RoA = 9.43% (Net Income 3.33b, Total Assets 35.27b )
RoE = 15.97% (Net Income TTM 3.33b / Total Stockholder Equity 20.82b)
RoCE = 21.72% (Ebit 4.96b / (Equity 20.82b + L.T.Debt 2.05b))
RoIC = 15.88% (NOPAT 3.71b / Invested Capital 23.34b)
WACC = 6.29% (E(28.40b)/V(32.10b) * Re(6.69%)) + (D(3.70b)/V(32.10b) * Rd(4.36%) * (1-Tc(0.25)))
Shares Correlation 5-Years: -87.20 | Cagr: -0.84%
Discount Rate = 6.69% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 77.93% ; FCFE base≈3.48b ; Y1≈3.40b ; Y5≈3.44b
Fair Price DCF = 238.1 (DCF Value 61.06b / Shares Outstanding 256.5m; 5y FCF grow -3.39% → 3.0% )
Revenue Correlation: 3.96 | Revenue CAGR: 3.02%
Rev Growth-of-Growth: 37.37
EPS Correlation: 32.92 | EPS CAGR: 26.46%
EPS Growth-of-Growth: 74.56